SCHEMBL10024562

SCHEMBL10024562

CC(C)(C)[Si](C)(C)O[Si](C)(CCCOCC(O)CN1CCN(CCO)CC1)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 4/20 0.39
USP2 O75604 1/20 0.39
ALOX15 P16050 1/20 0.39
TP53 P04637 1/20 0.37
ADRB2 P07550 1/20 0.36
HTT P42858 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
RAD52 P43351 1/20 0.35
GLA P06280 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1001608 0.87 LMNA (0.36) ALDH1A1KDM4EUSP2ALOX15HTT
SCHEMBL13912883 0.79 KDM4E (0.46) ALDH1A1KDM4EUSP2ALOX15HTT
SCHEMBL1001771 0.79 ALDH1A1 (0.40) ALDH1A1KDM4EUSP2ALOX15TP53
SCHEMBL1244968 0.79 ALDH1A1 (0.42) ALDH1A1KDM4EUSP2ALOX15TP53
SCHEMBL13705970 0.76 KDM4E (0.48) ALDH1A1KDM4EUSP2ALOX15HTT
SCHEMBL12153683 0.75 KDM4E (0.47) ALDH1A1KDM4EUSP2ALOX15HTT
SCHEMBL301624 0.74 KDM4E (0.48) ALDH1A1KDM4EUSP2ALOX15HTT
SCHEMBL301438 0.74 KDM4E (0.48) ALDH1A1KDM4EUSP2ALOX15HTT
SCHEMBL12153675 0.73 KDM4E (0.46) ALDH1A1KDM4EUSP2ALOX15HTT
SCHEMBL14514525 0.72 ALDH1A1 (0.45) ALDH1A1KDM4EUSP2ALOX15HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470894-B2 Hydrolysis resistant organomodified trisiloxane ionic surfactants MOMENTIVE PERFORMANCE MATERIALS (US) 2013-06-25 US disclosed
US-8470894-B2 Hydrolysis resistant organomodified trisiloxane ionic surfactants MOMENTIVE PERFORMANCE MATERIALS (US) 2013-06-25 US disclosed
US-8263669-B2 Hydrolysis resistant organomodified trisiloxane ionic surfactants MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2012-09-11 US disclosed
US-20120142535-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. 2012-06-07 US disclosed
US-20110028569-A1 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. 2011-02-03 US disclosed
US-20110021644-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. 2011-01-27 US disclosed
US-20090173912-A1 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-07-09 US disclosed
US-20090176893-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028569-A1 MIXTURES OF HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS CHRM1, CHRM2, CD209 ALDH1A1 4311/4885KDM4E 2604/4885USP2 754/4885
US-20090176893-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS CHRM2, CHRM1, MSR1 ALDH1A1 3424/4885KDM4E 1219/4885USP2 178/4885
US-20120142535-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE IONIC SURFACTANTS CHRM2, CHRM1, MSR1 ALDH1A1 3518/4885KDM4E 1089/4885USP2 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.